文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

微量支气管肺泡灌洗液淀粉酶水平在呼吸机相关性肺炎中的意义:一项前瞻性观察性研究

Significance of Mini Bronchoalveolar Lavage Fluid Amylase Level in Ventilator-Associated Pneumonia: A Prospective Observational Study.
PubMed 文献 · Crit Care Med · 2018-01-01
一句话结论插管72小时内,临床疑似呼吸机相关性肺炎且微量支气管肺泡灌洗液α-淀粉酶≥163 U/L者,诊断呼吸机相关性肺炎的敏感度73%、特异度68.6%。

这项前瞻性单中心观察性研究纳入151例机械通气超过48小时、临床疑似呼吸机相关性肺炎的成人患者,在气管插管72小时内采集微量支气管肺泡灌洗液检测α-淀粉酶并做定量培养,以灌洗液培养菌落≥10 cfu/mL确认呼吸机相关性肺炎。临床疑似患者中呼吸机相关性肺炎患病率为64.9%;呼吸机相关性肺炎组灌洗液α-淀粉酶中位数287 U/L(164-860 U/L),无呼吸机相关性肺炎组94 U/L(59-236 U/L),两组差异有统计学意义(p<0.001)。插管前误吸危险因素为0、1、2、3个者,α-淀粉酶中位数分别为65 U/L(35-106 U/L)、200 U/L(113-349 U/L)、867 U/L(353-1,425 U/L)、3,453 U/L(1,865-4,304 U/L)(p<0.001);插管后危险因素为1个和2个者分别为472 U/L(164-1,452 U/L)和731 U/L(203-1,403 U/L)(p<0.001)。灌洗液α-淀粉酶≥163 U/L诊断呼吸机相关性肺炎的敏感度73%、特异度68.6%,受试者工作特征曲线下面积0.746(95%CI 0.66-0.83)。

要点

  • 临床疑似呼吸机相关性肺炎的插管患者中,呼吸机相关性肺炎患病率为64.9%(151例中)。
  • 呼吸机相关性肺炎组微量支气管肺泡灌洗液α-淀粉酶中位数287 U/L(164-860 U/L),无呼吸机相关性肺炎组94 U/L(59-236 U/L),p<0.001。
  • 灌洗液α-淀粉酶≥163 U/L诊断呼吸机相关性肺炎的敏感度73%、特异度68.6%,曲线下面积0.746(95%CI 0.66-0.83)。
  • 插管前误吸危险因素0、1、2、3个者,α-淀粉酶中位数依次为65、200、867、3,453 U/L(p<0.001)。
  • 插管后误吸危险因素1个和2个者,α-淀粉酶中位数分别为472 U/L(164-1,452 U/L)和731 U/L(203-1,403 U/L)(p<0.001)。

适用人群与场景

  • 成人机械通气超过48小时、按既定标准临床疑似呼吸机相关性肺炎、2014年12月至2016年5月入住三级学术机构重症医学科的患者。
  • 微量支气管肺泡灌洗样本在气管插管72小时内采集。

诊断标准与关键阈值

  • 呼吸机相关性肺炎由微量支气管肺泡灌洗液微生物培养≥10 cfu/mL确认。
  • 微量支气管肺泡灌洗液α-淀粉酶≥163 U/L诊断呼吸机相关性肺炎的敏感度73%、特异度68.6%,曲线下面积0.746(95%CI 0.66-0.83)。

研究设计与关键结果

  • 研究类型为前瞻性单中心观察性研究,纳入151例临床疑似呼吸机相关性肺炎的机械通气成人患者。
  • 临床疑似患者中呼吸机相关性肺炎患病率为64.9%。
  • 呼吸机相关性肺炎组微量支气管肺泡灌洗液α-淀粉酶中位数287 U/L(164-860 U/L),无呼吸机相关性肺炎组94 U/L(59-236 U/L),p<0.001。
  • 插管前误吸危险因素0、1、2、3个者α-淀粉酶中位数分别为65 U/L(35-106 U/L)、200 U/L(113-349 U/L)、867 U/L(353-1,425 U/L)、3,453 U/L(1,865-4,304 U/L),p<0.001。
  • 插管后误吸危险因素1个和2个者α-淀粉酶中位数分别为472 U/L(164-1,452 U/L)和731 U/L(203-1,403 U/L),p<0.001。

证据类型、等级与局限

  • 证据类型为前瞻性单中心观察性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对插管72小时内临床疑似呼吸机相关性肺炎的成人患者,微量支气管肺泡灌洗液α-淀粉酶升高(≥163 U/L)可提示呼吸机相关性肺炎,但敏感度73%、特异度68.6%,不能单独作为确诊依据。
  • 插管前误吸危险因素数量越多,微量支气管肺泡灌洗液α-淀粉酶中位数越高(0个65 U/L至3个3,453 U/L),可结合危险因素数量解读该指标。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Aspiration of oropharyngeal or gastric contents in intubated patients can lead to ventilator-associated pneumonia. Amylase in respiratory secretion has been reported as a possible marker of aspiration. We studied whether elevated α-amylase in mini bronchoalveolar lavage specimens can be suggestive of ventilator-associated pneumonia in intubated patients with high clinical suspicion.

DESIGN: Prospective single-center observational study.

SETTING: Department of Critical Care Medicine, tertiary care academic institute.

PATIENTS: Adult patients on mechanical ventilation for more than 48 hours with with clinically suspected ventilator-associated pneumonia as per defined criteria, admitted between December 2014 and May 2016.

METHODS: Mini bronchoalveolar lavage samples were collected within 72 hours of endotracheal intubation. Samples were sent for α-amylase level assay and quantitative culture. Ventilator-associated pneumonia was confirmed from mini bronchoalveolar lavage microbial culture of greater than or equal to 10 cfu/mL, and patients were divided into ventilator-associated pneumonia and no ventilator-associated pneumonia groups. Pre- and postintubation risk factors for aspiration were also noted.

RESULTS: The prevalence of ventilator-associated pneumonia was 64.9% among 151 patients in whom it was clinically suspected. Median (interquartile range) mini bronchoalveolar lavage α-amylase levels in ventilator-associated pneumonia and no ventilator-associated pneumonia groups on the day of study inclusion were 287 U/L (164-860 U/L) and 94 U/L (59-236 U/L), respectively (p < 0.001). Median (interquartile range) α-amylase levels in patients with 0, 1, 2, and 3 preintubation risk factors were 65 U/L (35-106 U/L), 200 U/L (113-349 U/L), 867 U/L (353-1,425 U/L), and 3,453 U/L (1,865-4,304 U/L), respectively (p < 0.001) and 472 U/L (164-1,452 U/L) and 731 U/L (203-1,403 U/L) in patients with 1 and 2 postintubation risk factors, respectively (p < 0.001). A mini bronchoalveolar lavage α-amylase of 163 U/L or more yielded sensitivity and specificity of 73% and 68.6%, respectively, with area under the receiver operating characteristic curve of 0.746 (95% CI, 0.66-0.83).

CONCLUSIONS: Patients with ventilator-associated pneumonia within 72 hours from intubation have significantly elevated α-amylase concentrations in mini bronchoalveolar lavage fluid. Mini bronchoalveolar lavage α-amylase concentrations increase with increasing number of aspiration risk factors.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Samanta S, Poddar B, Azim A, et al. Significance of Mini Bronchoalveolar Lavage Fluid Amylase Level in Ventilator-Associated Pneumonia: A Prospective Observational Study. Crit Care Med. 2018. PMID: 29053492. doi:10.1097/CCM.0000000000002774

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。